The drug, RK-33, also prevented cancer cells in the bone from spreading to other body parts Peer-Reviewed Publication Johns Hopkins Medicine In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to...
Tag: <span>Cancer Drug</span>
Post
Cancer drug could be used to save the limbs of peripheral artery disease patients, pre-clinical study suggests
Credit: Science Advances (2024). DOI: 10.1126/sciadv.adn8760 Researchers at the Heart Research Institute (HRI) have made a new discovery, finding an existing drug used to kill tumor cells in cancer patients could also be used to save the limbs of patients with blocked arteries in their legs. A pre-clinical study by HRI’s Center for Peripheral Artery Disease (PAD)...
Post
One man’s mission to revive a forgotten, life-saving cancer drug
Dutch immunologist Jacques Neefjes believes the drug aclarubicin, unavailable in Europe for 20 years, could have helped 100,000 people with a rare blood cancer Eva AmsenSat 27 Jul 2024 12.00 EDT For the past decade, the Dutch immunologist Jacques (Sjaak) Neefjes has been on a mission to bring back a cancer drug that hasn’t been...
Post
Cancer drug could hold hope for treating inflammatory diseases including gout and heart diseases
by University of Cambridge Graphical abstract. Credit: Journal of Clinical Investigation (2023). DOI: 10.1172/JCI162129 A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say scientists at the University of Cambridge. In a study,...
Post
First-of-its-kind cancer drug targets mechanism that causes metastasis
By Paul McClure August 03, 2023 Researchers have developed an monoclonal antibody drug that targets the process that causes cancer cells to spread in the body Depositphotos Metastatic cancer accounts for up to 90% of all cancer deaths in the US annually. But with researchers developing a first-of-its-kind drug that inhibits the process by which cancer cells...
Post
Cancer drug from Pfizer appears to stop aneurysm growth, opening door to nonsurgical treatment
By Helen Floersh Jun 14, 2023 02:00 Cancer drug from Pfizer appears to stop aneurysm growth, opening door to nonsurgical treatment. Researchers found that a mutation in the gene PDGFRB was present throughout an aneurysm’s tissue layers, which helped explain the mechanics behind its formation. (Getty Images) About five of every 100 people have a...
Post
Experimental cancer drug could be effective in treating idiopathic pulmonary fibrosis
by National Jewish Health Credit: Pixabay/CC0 Public Domain Researchers have shown that the medication saracatinib shows promise as a treatment for idiopathic pulmonary fibrosis (IPF). Saracatinib worked as well or better than two approved drugs at reducing tissue scarring in preclinical models of IPF according to the study published in the American Journal of Respiratory and...
Post
Through the lymph nodes it goes — researchers develop a cancer drug that avoids toxicities by skirting the liver
PI3K is a protein that is part of a pathway that regulates cell growth, survival and metabolism — earning it the inscription of master regulator for cancer. However, while a number of PI3K inhibitor drugs have been approved since 2014, the class as a whole has dwindled, as it has been plagued by toxicity issues...
Post
Cancer drug shows potential as treatment for muscular dystrophy
by University of British Columbia Effects of CSF1R inhibitors – and the absence of self-renewing resident macrophages – on muscle regeneration in mice. Credit: F. Babaeijandaghi, et al., Science Translational Medicine (2022) Researchers at the University of British Columbia’s School of Biomedical Engineering have discovered that an existing cancer drug could have potential as a treatment for muscular...
Post
‘First time this has happened’: Doctors left shocked after clinical trial for cancer drug cures the disease in EVERY participant
By MANSUR SHAHEEN U.S. DEPUTY HEALTH EDITOR FOR DAILYMAIL.COM PUBLISHED: 16:59 EDT, 6 June 2022 | UPDATED: 18:07 EDT, 6 June 2022 A new colorectal cancer drug has shocked researchers with how effective it is against the highly dangerous disease, as it virtually cured it in every member of a clinical trial. Dostarlimab, a monoclonal antibody drug, smashed expectations in...